University of Bonn / Department of Psychiatry
Bonn, North Rhine-Westphalia, 53111, Germany
NCT Number: NCT02711371
The aim of this functional magnetic resonance imaging (fMRI) study is to find out whether and how social and emotional brain function are altered in dependent cannabis users relative to healthy non-using control subjects after a 28 supervised abstinence period. Previous research in cannabis users has predominantly focused on cognitive functions. Moreover, studies have implicated that observed deficits in cannabis users may regenerate after a prolonged abstinence period. Findings might provide important information with respect to relapse vulnerability.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Observational
Bonn, North Rhine-Westphalia, 53111, Germany
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: one timepoint = fMRI assessment after 28 day abstinence period
Activity patterns in core regions of the emotion processing & addiction-related brain networks (e.g. striatal regions, insular cortex, prefrontal cortex) will be assessed after 28-days of abstinence. Alterations will be determined by comparison with matched non-drug using controls
Time frame: one timepoint = during fMRI assessment after 28 day abstinence period
Self-reported ratings of pleasantness & rewarding value during soft-pleasant touch.
Time frame: one timepoint = 24 months post-fMRI-session
Association between fMRI neural correlates and drug use during follow up period as predictor of relapse
University of Electronic Science and Technology of China
Other
Long-term Effects of Cannabis Use on Social and Emotional Brain Processes in Dependent Cannabis Users After a 28 Day Abstinence Period
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07340554
Addiction, Addiction, Substance
Indianapolis, Indiana, United States
View Trial DetailsNCT05219825
Addiction, Behavior
New York, United States
View Trial DetailsNCT01793961
Cannabis Dependence, Chemically-Induced Disorders
Strasbourg, Bas-Rhin, France
View Trial DetailsNCT03104257
Cannabis Dependence, Chemically-Induced Disorders
New Haven, Connecticut, United States
View Trial Details